ADA-2 gene mutation in a Crohn's disease patient without response to therapy

J Gastrointestin Liver Dis. 2024 Mar 30;33(1):134-135. doi: 10.15403/jgld-5271.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Crohn Disease* / diagnosis
  • Crohn Disease* / drug therapy
  • Crohn Disease* / genetics
  • Humans
  • Mutation
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha

Substances

  • Adalimumab
  • Tumor Necrosis Factor-alpha